These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 17045309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
    Römermann K, Helmer R, Löscher W.
    Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
    Luna-Tortós C, Fedrowitz M, Löscher W.
    Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
    [Abstract] [Full Text] [Related]

  • 4. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C, Fedrowitz M, Löscher W.
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
    Hoffmann K, Löscher W.
    Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
    [Abstract] [Full Text] [Related]

  • 8. Potential role for human P-glycoprotein in the transport of lacosamide.
    Zhang C, Chanteux H, Zuo Z, Kwan P, Baum L.
    Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.
    Booth-Genthe CL, Louie SW, Carlini EJ, Li B, Leake BF, Eisenhandler R, Hochman JH, Mei Q, Kim RB, Rushmore TH, Yamazaki M.
    J Pharmacol Toxicol Methods; 2006 Jul; 54(1):78-89. PubMed ID: 16545584
    [Abstract] [Full Text] [Related]

  • 11. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S.
    Pharm Res; 2006 Jul; 23(7):1460-72. PubMed ID: 16779700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K, Luna-Tortós C, Ambroziak K, Löscher W.
    Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
    [Abstract] [Full Text] [Related]

  • 14. The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteins.
    Luna-Tortós C, Rambeck B, Jürgens UH, Löscher W.
    Pharm Res; 2009 Nov; 26(11):2464-70. PubMed ID: 19730994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Bankstahl M, Klein S, Römermann K, Löscher W.
    Neuropharmacology; 2016 Oct; 109():183-195. PubMed ID: 27288003
    [Abstract] [Full Text] [Related]

  • 17. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM, Usta M, van der Velde AE, Boersma MG, Spenkelink B, van Zanden JJ, Rietjens IM, van Bladeren PJ, Cnubben NH.
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [Abstract] [Full Text] [Related]

  • 18. Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
    Katoh M, Suzuyama N, Takeuchi T, Yoshitomi S, Asahi S, Yokoi T.
    J Pharm Sci; 2006 Dec; 95(12):2673-83. PubMed ID: 16892207
    [Abstract] [Full Text] [Related]

  • 19. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
    Cerveny L, Pavek P, Malakova J, Staud F, Fendrich Z.
    Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
    [Abstract] [Full Text] [Related]

  • 20. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
    Swed A, Eyal S, Madar I, Zohar-Kontante H, Weiss L, Hoffman A.
    Mol Pharm; 2009 Mar; 6(6):1883-90. PubMed ID: 19722701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.